Fundz

Restore Medical raises $23M in Series B to advance its heart failure therapy, led by Pitango HealthTech and a strategic partner.

PRIVATEJul 07, 2025

Amount Raised

$23 Million

Round Type

Series B

Or YehudaBiotechnologyHealth CareMedical

Investors

Pitango HealthTechPeregrine VenturesEuropean Innovation Council Fund

Description

Restore Medical has secured $23 million in Series B funding to advance its minimally invasive heart failure device. The round is co-led by Pitango HealthTech and an undisclosed global healthcare partner. The capital will support ongoing studies in Europe and a planned U.S. clinical trial

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Restore Medical that raised within 45 days of this round, from Fundz verified event records.

  • Method AI raised $20M (Series A) on August 21, 2025.
  • RIVANNA raised $800K (Grant) on August 15, 2025.
  • Citizen Health raised $30M (Series A) on August 15, 2025.
  • Liberate Medical raised $4.5M (Seed) on August 15, 2025.
  • Conformal Medical raised $32M (Series D) on August 12, 2025.
  • Apreo Health raised $130M (Series B) on August 7, 2025.

Who to call at Restore Medical, and when

A new round usually means Restore Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Restore Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Restore Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Restore Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Restore Medical

Location

Or Yehuda, Tel Aviv District, Israel

About

Restore Medical is an Israeli clinical-stage medical technology company focused on developing a minimally invasive device to treat heart failure. The company's innovative approach aims to address gaps in current heart failure therapies by providing a transcatheter solution that does not require open-heart surgery. With promising early results indicating improved cardiac remodeling and patient outcomes, Restore Medical is advancing its technology through clinical trials in Europe and the U.S. The company has secured significant funding to support its ongoing research and regulatory efforts.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Restore Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Restore Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Restore Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.